CTOs on the Move

Ergatta

www.ergatta.com

 
Ergatta is changing the motivation that moves people. We are a team of bright, driven, and innovative thinkers on a mission to build a new consumer category: game-based home fitness.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Ergatta raised $30M on 04/28/2021

Similar Companies

Amerimed

Amerimed Medical Solutions is a healthcare company that provides emergency medical services and mobile integrated healthcare in several states in the US.

Symbria

At Symbria, we unite passion, insight, and performance to help senior-living and post-acute providers build sustainable success. We don`t make this commitment lightly, understanding full well how challenging this goal is to achieve in today`s demanding, highly competitive environment. Every service we provide – from therapy to pharmacy to wellness to benchmarking – is thoughtfully developed and conscientiously implemented to amplify your ability to effectively and cost-efficiently meet the needs of the residents and patients your community serves.

Lumo Bodytech

Lumo Bodytech has developed a technology platform that leverages smart sensors and software to optimize performance and address human biomechanics through the real-time tracking of body movement. Lumo’s products empower you to be the best version of yourself. Current Lumo Bodytech products include the Lumo Lift and Lumo Back posture coaches and activity trackers, as well as the Lumo Run smart running shorts.

Belmont Manor Nursing Home Inc

Belmont Manor Nursing Home Inc is a Belmont, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.